Search Results
Matches for acronym mr
228
rows returned
Results are ranked by score and user rating. Use the quick vote buttons when a candidate clearly matches or clearly does not.
| Acronym | Full Name | Score | User Rating | Judge | Search |
|---|---|---|---|---|---|
| Mr | Magnetic resonance | 2208 | 2 |
|
|
| Mr | mitral regurgitation | 193 | 4 |
|
|
| Mr | molecular weight | 129 | 5 |
|
|
| Mr | mineralocorticoid receptor | 113 | 5 |
|
|
| Mr | Molecular mass | 69 | 3 |
|
|
| Mr | Magnetic resonance imaging | 30 | 5 |
|
|
| Mr | mol wt | 29 | 3 |
|
|
| Mr | molecular weights | 26 | 5 |
|
|
| Mr | metabolic ratio | 25 | 1 |
|
|
| Mr | metabolic rate | 23 | 3 |
|
|
| Mr | mineralocorticoid receptors | 18 | 5 |
|
|
| Mr | mass | 15 | 4 |
|
|
| Mr | minor response | 13 | 8 |
|
|
| Mr | mortality rate | 11 | 5 |
|
|
| Mr | mannose receptor | 10 | -1 |
|
|
| Mr | mitochondria-rich | 9 | 5 |
|
|
| Mr | mineralocorticoid | 9 | 0 |
|
|
| Mr | median raphe nucleus | 8 | 7 |
|
|
| Mr | Maudsley reactive | 8 | 3 |
|
|
| Mr | molecular masses | 8 | 3 |
|
|
| Mr | mentally retarded | 7 | 4 |
|
|
| Mr | median raphe | 7 | 2 |
|
|
| Mr | mitotic rate | 7 | -1 |
|
|
| Mr | mortality ratio | 6 | 5 |
|
|
| Mr | mitral valve regurgitation | 5 | 7 |
|
|
| Mr | Mannose-resistant | 5 | 7 |
|
|
| Mr | Mannose resistant | 4 | 5 |
|
|
| Mr | methicillin resistant | 4 | 4 |
|
|
| Mr | milk replacer | 4 | 4 |
|
|
| Mr | methicillin-resistant | 4 | 3 |
|
|
| Mr | mother-reared | 4 | 2 |
|
|
| Mr | medial rectus | 3 | 7 |
|
|
| Mr | metabolic rates | 3 | 6 |
|
|
| Mr | mortality rate ratio | 3 | 6 |
|
|
| Mr | molar ratio | 3 | 5 |
|
|
| Mr | mismatch repair | 3 | 5 |
|
|
| Mr | mental rotation | 3 | 5 |
|
|
| Mr | metabolic reaction | 3 | 3 |
|
|
| Mr | muscle relaxants | 3 | 2 |
|
|
| Mr | 31P-magnetic resonance | 2 | 8 |
|
|
| Mr | minor responses | 2 | 8 |
|
|
| Mr | molar refractivity | 2 | 7 |
|
|
| Mr | modified release | 2 | 6 |
|
|
| Mr | Maillard reaction | 2 | 6 |
|
|
| Mr | mitral regurgitation (IMR) is mitral regurgitation | 2 | 5 |
|
|
| Mr | mean discharge rate | 2 | 5 |
|
|
| Mr | multiresistant | 2 | 5 |
|
|
| Mr | multiple regression | 2 | 5 |
|
|
| Mr | myogenic response | 2 | 5 |
|
|
| Mr | mouse renal | 2 | 5 |
|
|
| Mr | methicillin resistance | 2 | 4 |
|
|
| Mr | minimal response | 2 | 4 |
|
|
| Mr | microradiography | 2 | 4 |
|
|
| Mr | myocardial revascularization | 2 | 3 |
|
|
| Mr | molecular size | 2 | 3 |
|
|
| Mr | magnetic-resonance | 2 | 2 |
|
|
| Mr | morbid risk | 2 | 2 |
|
|
| Mr | molecular radius | 2 | 2 |
|
|
| Mr | metabolic ratios | 2 | 1 |
|
|
| Mr | mannose receptors | 2 | 0 |
|
|
| Mr | morbidity risk | 1 | 10 |
|
|
| Mr | magnetic resonance tomogram | 1 | 10 |
|
|
| Mr | molecular weight of approximately 70 kDa | 1 | 9 |
|
|
| Mr | mixed response | 1 | 9 |
|
|
| Mr | microvascular resistance | 1 | 8 |
|
|
| Mr | mileage runners | 1 | 8 |
|
|
| Mr | medium | 1 | 8 |
|
|
| Mr | mitral | 1 | 8 |
|
|
| Mr | menstrual regulation | 1 | 8 |
|
|
| Mr | masses | 1 | 8 |
|
|
| Mr | morphinone reductase | 1 | 8 |
|
|
| Mr | motor response | 1 | 7 |
|
|
| Mr | min marathon | 1 | 7 |
|
|
| Mr | mouse recombinant | 1 | 7 |
|
|
| Mr | Mari-Russian | 1 | 7 |
|
|
| Mr | mouse erythrocytes | 1 | 7 |
|
|
| Mr | major response | 1 | 7 |
|
|
| Mr | Mantoux reaction | 1 | 7 |
|
|
| Mr | major relative molecular weight | 1 | 7 |
|
|
| Mr | molecular-weight | 1 | 7 |
|
|
| Mr | mitogen-induced response | 1 | 7 |
|
|
| Mr | mirror-reversed | 1 | 7 |
|
|
| Mr | molecule had a relative molecular weight | 1 | 7 |
|
|
| Mr | high-molecular-weight | 1 | 7 |
|
|
| Mr | minimum molecular weight | 1 | 7 |
|
|
| Mr | Mitsuda reaction | 1 | 7 |
|
|
| Mr | males | 1 | 6 |
|
|
| Mr | multiple response | 1 | 6 |
|
|
| Mr | molar refractivities | 1 | 6 |
|
|
| Mr | methylenetetrahydrofolate reductase | 1 | 6 |
|
|
| Mr | 000-relative-molecular-weight | 1 | 6 |
|
|
| Mr | myosin of relative molecular mass | 1 | 6 |
|
|
| Mr | Metropolitan Region | 1 | 6 |
|
|
| Mr | mutation rates | 1 | 6 |
|
|
| Mr | multiplicity reactivation | 1 | 6 |
|
|
| Mr | mainly from the median | 1 | 6 |
|
|
| Mr | magnetization transfer ratio and (1)H-magnetic resonance | 1 | 6 |
|
|
| Mr | muscle relaxation appliance | 1 | 6 |
|
|
| Mr | Methyl Red | 1 | 6 |
|
|
| Mr | malleus removal | 1 | 6 |
|
|
| Mr | mammalian Type I | 1 | 6 |
|
|
| Mr | men with recurrent stone | 1 | 6 |
|
|
| Mr | men with recurrent stones | 1 | 6 |
|
|
| Mr | membrane glycoprotein of molecular weight | 1 | 6 |
|
|
| Mr | molecular weight of the DNA | 1 | 6 |
|
|
| Mr | menisci) referred for magnetic resonance | 1 | 6 |
|
|
| Mr | masseter | 1 | 6 |
|
|
| Mr | medium region | 1 | 6 |
|
|
| Mr | mental retardation of different etiology | 1 | 6 |
|
|
| Mr | Moore-Read | 1 | 6 |
|
|
| Mr | matted row | 1 | 6 |
|
|
| Mr | Multicentric Reticulohistiocytosis | 1 | 6 |
|
|
| Mr | maps reconstructed from dynamic magnetic resonance | 1 | 6 |
|
|
| Mr | metabolic cost of running | 1 | 6 |
|
|
| Mr | mentally retarded subjects without DS | 1 | 6 |
|
|
| Mr | mass ratios | 1 | 6 |
|
|
| Mr | HLA-matched related | 1 | 5 |
|
|
| Mr | myocardial revascularisation (MR) and combined surgery | 1 | 5 |
|
|
| Mr | 000-molecular weight (relative) | 1 | 5 |
|
|
| Mr | most common abnormalities included signal alterations | 1 | 5 |
|
|
| Mr | mitotic regimen | 1 | 5 |
|
|
| Mr | mechanoreceptor cells | 1 | 5 |
|
|
| Mr | mandelate racemase | 1 | 5 |
|
|
| Mr | mouse rosettes | 1 | 5 |
|
|
| Mr | male | 1 | 5 |
|
|
| Mr | mental retardation* | 1 | 5 |
|
|
| Mr | major apolipoprotein of apparent molecular weight | 1 | 5 |
|
|
| Mr | medial | 1 | 5 |
|
|
| Mr | mineralocorticoid (type I) receptor | 1 | 5 |
|
|
| Mr | magnetic resonance imaging of the brain | 1 | 5 |
|
|
| Mr | modal resistance | 1 | 5 |
|
|
| Mr | mitral repair | 1 | 4 |
|
|
| Mr | mother reared | 1 | 4 |
|
|
| Mr | Myocardial 31P-magnetic resonance | 1 | 4 |
|
|
| Mr | monomer with a relative molecular weight | 1 | 4 |
|
|
| Mr | molar plasma concentration ratio | 1 | 4 |
|
|
| Mr | muscle relaxant | 1 | 4 |
|
|
| Mr | mitral regurgitant | 1 | 4 |
|
|
| Mr | myocardial reperfusion | 1 | 4 |
|
|
| Mr | model bias in molecular-replacement | 1 | 4 |
|
|
| Mr | muscarinic receptors | 1 | 4 |
|
|
| Mr | magnitude ratios | 1 | 4 |
|
|
| Mr | metformin after administration of modified-release | 1 | 4 |
|
|
| Mr | metaraminol | 1 | 4 |
|
|
| Mr | cycle--monodehydroascorbate reductase | 1 | 4 |
|
|
| Mr | mentally rehearsed | 1 | 4 |
|
|
| Mr | membranes at apparent molecular weights | 1 | 4 |
|
|
| Mr | membrane-bound receptors | 1 | 4 |
|
|
| Mr | melatonin receptors | 1 | 4 |
|
|
| Mr | low-molecular-weight | 1 | 4 |
|
|
| Mr | median reduction | 1 | 4 |
|
|
| Mr | measles-rubella vaccine | 1 | 4 |
|
|
| Mr | measure the exact molecular weight | 1 | 4 |
|
|
| Mr | measure residual mitral regurgitation | 1 | 4 |
|
|
| Mr | maximal binding ratios | 1 | 4 |
|
|
| Mr | maxillary retrusion | 1 | 4 |
|
|
| Mr | magnetic response | 1 | 4 |
|
|
| Mr | mg/1000 kcal | 1 | 4 |
|
|
| Mr | middle (NF-M) molecular weight | 1 | 4 |
|
|
| Mr | manner as the motility-regulating | 1 | 4 |
|
|
| Mr | Radiology | 1 | 4 |
|
|
| Mr | cine-magnetic resonance imaging | 1 | 4 |
|
|
| Mr | mice has relative molecular mass | 1 | 4 |
|
|
| Mr | major IGFBP had a mol wt | 1 | 3 |
|
|
| Mr | motor representations | 1 | 3 |
|
|
| Mr | Miniruby | 1 | 3 |
|
|
| Mr | magnetic resonance images | 1 | 3 |
|
|
| Mr | Multireceptive | 1 | 3 |
|
|
| Mr | miniresective 'bowel-sparing' techniques | 1 | 3 |
|
|
| Mr | mount rate | 1 | 3 |
|
|
| Mr | murine recombinant | 1 | 3 |
|
|
| Mr | Maillard reactions | 1 | 3 |
|
|
| Mr | 000-molecular weight | 1 | 3 |
|
|
| Mr | NADH-methaemoglobin reductase | 1 | 3 |
|
|
| Mr | mouse strains bearing Flv(r)-like and Flv | 1 | 3 |
|
|
| Mr | MS and methicillin-resistant | 1 | 3 |
|
|
| Mr | Manifestation rate | 1 | 3 |
|
|
| Mr | molecular weight range | 1 | 3 |
|
|
| Mr | male-recombination promoting elements | 1 | 3 |
|
|
| Mr | minimal resuscitation | 1 | 3 |
|
|
| Mr | melatonin receptor | 1 | 3 |
|
|
| Mr | measles-rubella | 1 | 3 |
|
|
| Mr | medicine resident/faculty physician clinic | 1 | 3 |
|
|
| Mr | mock resuscitation scenarios | 1 | 3 |
|
|
| Mr | moderate | 1 | 3 |
|
|
| Mr | molecular remission | 1 | 3 |
|
|
| Mr | milk release | 1 | 3 |
|
|
| Mr | N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-resistant | 1 | 3 |
|
|
| Mr | monosynaptic reflex | 1 | 3 |
|
|
| Mr | minor | 1 | 3 |
|
|
| Mr | molar masses | 1 | 3 |
|
|
| Mr | M2-muscarinic receptor | 1 | 3 |
|
|
| Mr | menstrual regulation procedures | 1 | 3 |
|
|
| Mr | monokine of relative molecular weight | 1 | 3 |
|
|
| Mr | molecular replacement | 1 | 2 |
|
|
| Mr | Macronuclear retention | 1 | 2 |
|
|
| Mr | manner by mineralocorticoid | 1 | 2 |
|
|
| Mr | mucPR and the mitochondrial mucidin-resistance gene | 1 | 2 |
|
|
| Mr | metabolic ratio of debrisoquine/4-OH-debrisoquine | 1 | 2 |
|
|
| Mr | medial raphe nucleus | 1 | 2 |
|
|
| Mr | mortality rates | 1 | 2 |
|
|
| Mr | Monte Ruscello | 1 | 2 |
|
|
| Mr | M3-muscarinic receptors | 1 | 2 |
|
|
| Mr | matching the rhymes | 1 | 2 |
|
|
| Mr | masseteric reflex | 1 | 2 |
|
|
| Mr | medium risk | 1 | 2 |
|
|
| Mr | manifest refraction | 1 | 1 |
|
|
| Mr | macroreticular | 1 | 1 |
|
|
| Mr | myogenic responses | 1 | 1 |
|
|
| Mr | magnetic resonance tomography | 1 | 1 |
|
|
| Mr | mRNA levels of the mineralocorticoid | 1 | 1 |
|
|
| Mr | moderately restricted | 1 | 1 |
|
|
| Mr | mechanical restitution | 1 | 1 |
|
|
| Mr | middle (NFP-M) molecular weight | 1 | 1 |
|
|
| Mr | might result in a mental retardation | 1 | 1 |
|
|
| Mr | meal replacement | 1 | 1 |
|
|
| Mr | maximum risk | 1 | 1 |
|
|
| Mr | mosquito repellent | 1 | 1 |
|
|
| Mr | Maudsley reactives | 1 | 1 |
|
|
| Mr | mouse erythrocyte receptor | 1 | 1 |
|
|
| Mr | migrating with apparent mol wt | 1 | 0 |
|
|
| Mr | mirror repeat | 1 | 0 |
|
|
| Mr | monomeric ribosomes | 1 | 0 |
|
|
| Mr | molecular wt | 1 | 0 |
|
|
| Mr | motor representation | 1 | 0 |
|
|
| Mr | Margin of reliability | 1 | -1 |
|
|
| Mr | modal relative molecular mass | 1 | -1 |
|
|
| Mr | molecular mass of the protein | 1 | -2 |
|
Run A Search
Search either direction
By Acronym
By Full Name